Financhill
Back

VYNE Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
27

VYNE
VYNE Therapeutics

Last Price:
1.89
Seasonality Move:
-14.98%
Sell
26

NBY
NovaBay Pharmaceuticals

Last Price:
0.51
Seasonality Move:
-14.79%
Sell
27
VYNE Therapeutics (VYNE) is a Sell

Is VYNE Therapeutics a Buy, Sell or Hold?

  • The current VYNE Therapeutics [VYNE] share price is $1.86. The Score for VYNE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • VYNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.51. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VYNE Stock Price Chart

What is VYNE Therapeutics's stock price today?

  • The VYNE Therapeutics share price today is $1.86
    The current trend is relatively stagnant and VYNE is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

VYNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50.45 Buy
Chaikin Money Flow: -40914 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 1.89) Buy
Bollinger Bands (100): (1.77 - 2.49) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: -38478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Buy
Bollinger Bands (100): (0.61 - 3.39) Sell

VYNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.84 Buy
20-day SMA: 1.85 Buy
50-day SMA: 1.9 Sell
200-day SMA: 2.25 Sell
8-day EMA: 1.85 Buy
20-day EMA: 1.85 Buy
50-day EMA: 1.91 Sell
200-day EMA: 2.47 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.48 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.89 Sell
200-day SMA: 3.84 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.97 Sell
200-day EMA: 8.42 Sell

VYNE Therapeutics Earnings Growth & VYNE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $1.05 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

VYNE Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):